Human Epigenome Project

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Human Epigenome Project (HEP) is a multinational science project, with the stated aim to "identify, catalog, and interpret genome-wide DNA methylation patterns of all human genes in all major tissues".[1] It is financed by government funds as well as private investment, via a consortium of genetic research organisations.

The call for such a project was widely suggested and supported by cancer research scientists from all over the world.[2][3][4][5]

Consortium[edit]

The HEP consortium is made up of the following organizations:

  • The Wellcome Trust Sanger Institute — UK
  • Epigenomics AG — Germany/USA
  • The Centre National de Génotypage — France

References[edit]

  1. ^ "Description Page". Human Epigenome Project. Retrieved 2009-01-30. 
  2. ^ Esteller M (2006). "The necessity of a human epigenome project". Carcinogenesis 27 (6): 1121–1125. doi:10.1093/carcin/bgl033. PMID 16699174. 
  3. ^ Jones PA, Martienssen R (2005). "A blueprint for a Human Epigenome Project: the AACR Human Epigenome Workshop". Cancer Res 65 (24): 11241–11246. doi:10.1158/0008-5472.CAN-05-3865. PMID 16357125. 
  4. ^ Rauscher FJ 3rd (2005). "It is time for a Human Epigenome Project". Cancer Res 65 (24): 11229. doi:10.1158/0008-5472.can-65-24-ed1. PMID 1635712. 
  5. ^ Bradbury J (2003). "Human epigenome project--up and running". PLoS Biol 1 (3): E82. doi:10.1371/journal.pbio.0000082. PMC 300691. PMID 14691553. 

External links[edit]